The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins
Open accessAbstract
Omega‐3‐polyunsaturated fatty acids (w‐3‐PUFAs) have well‐documented protective effects that are attributed not only to eicosanoid inhibition but also to the formation of novel biologically active lipid mediators (i.e ., resolvins and protectins). In this study, we examined their effects on ob/ob mice, an obesity model of insulin resistance and fatty liver disease. Dietary intake ofw‐3‐PUFAs had insulin‐sensitizing actions in adipose tissue and liver and improved insulin tolerance in obese mice. Genes involved in insulin sensitivity (PPAR/γ), glucose transport (GLUT‐2/GLUT–4), and insulin receptor signaling (IRS‐1/IRS–2) were up‐regulated byw‐3‐PUFAs. Moreover,w‐3‐PUFAs increased adiponectin, an anti‐inflammatory and insulin‐sensitizing adipokine, and induced AMPK phosphorylation, a fuel‐sensing enzyme and a gatekeeper of the energy balance. Concomitantly, hepatic steatosis was alleviated byw‐3‐PUFAs. A lipidomic analysis with liquid chromatography/mass spectrome‐try/mass spectrometry revealed that w‐3‐PUFAs inhibited the formation of w‐6‐PUFA‐derived eicosanoids, while triggering the formation of w‐3‐PUFA‐derived resolvins and protectins. Moreover, representative members of these lipid mediators, namely resolvin E1 and protectin D1, mimicked the insulin‐sensitizing and antisteatotic effects of w‐3‐PUFAs and induced adiponectin expression to a similar extent that of rosigli‐tazone, a member of the thiazolidinedione family of antidiabetic drugs. Taken together, these findings uncover beneficial actions of w‐3‐PUFAs and their bioactive lipid autacoids in preventing obesity‐induced insulin resistance and hepatic steatosis.—Gonzalez‐Periz, A.,Horrillo, R., Ferre, N., Gronert, K., Dong, B., Moran‐Salvador, E.,Titos, E., Martinez‐Clemente, M.,Lopez‐Parra, M.,Arroyo, V., Claria, J. Obesity‐induced insulin resistance and hepatic steatosis are alleviated byw‐3 fatty acids: a role for resolvins and protectins. FASEB J. 23, 1946–1957 (2009)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reeves, P. G., Nielsen, F. H., & Fahey, G. C. (1993) · The Journal of Nutrition · doi:10.1093/jn/123.11.1939 · Cited by 8,709
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationNonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,296
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
AMP-activated protein kinase signaling in metabolic regulation
Long, Y. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29044 · Cited by 1,098
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000 · cited 2×
“These novel oxygenated products originated from -3PUFAs evoke potent protective actions demonstrable at the nanomolar and picomolar ranges, many of which are related to the resolution of unremitting inflammation (12, 16-20, 36, 46-48).”
BackgroundSelf-citationSerhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Nonalcoholic fatty liver disease
Clark, J. M., Brancati, F. L., & Diehl, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33573 · Cited by 901
Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome
Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., Collier, G., Walder, K., & Segal, D. (2007) · Endocrinology · doi:10.1210/en.2007-0175 · Cited by 858
Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism
Goralski, K. B., McCarthy, T. C., Hanniman, E. A., Zabel, B. A., Butcher, E. C., Parlee, S. D., Muruganandan, S., & Sinal, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700793200 · Cited by 857
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Self-citationConnor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D., et al. (2007) · Nature Medicine · doi:10.1038/nm1591 · Cited by 688
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 673
Nawrocki, A. R., Rajala, M. W., Tomas, E., Pajvani, U. B., Saha, A. K., Trumbauer, M. E., Pang, Z., Chen, A. S., Ruderman, N. B., Chen, H., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505311200 · Cited by 639
Arita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3912 · Cited by 633
Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., & Serhan, C. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409271102 · Cited by 590
Endocrine and signalling role of adipose tissue: new perspectives on fat
Trayhurn, P. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01468.x · Cited by 502
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
Kamada, Y., Tamura, S., Kiso, S., Matsumoto, H., Saji, Y., Yoshida, Y., Fukui, K., Maeda, N., Nishizawa, H., Nagaretani, H., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.029 · Cited by 479
Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., & Levy, B. D. (2008) · Nature Immunology · doi:10.1038/ni.1627 · Cited by 424
Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., & Chan, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-112201 · Cited by 414 · cited 1×
“(49) who demonstrated that a deficit in the biosynthesis of -3PUFA-derived lipid autacoids is involved in the progression of atherosclerosis, a disease also closely related to the metabolic syndrome.”
BackgroundAdiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
Masaki, T., Chiba, S., Tatsukawa, H., Yasuda, T., Noguchi, H., Seike, M., & Yoshimatsu, H. (2004) · Hepatology · doi:10.1002/hep.20282 · Cited by 402
Chemerin—A new adipokine that modulates adipogenesis via its own receptor
Roh, S.-G., Song, S.-H., Choi, K.-C., Katoh, K., Wittamer, V., Parmentier, M., & Sasaki, S.-I. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.104 · Cited by 361
Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue
Yu, Y.-H., & Ginsberg, H. N. (2005) · Circulation Research · doi:10.1161/01.res.0000165803.47776.38 · Cited by 326
Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid
Culp, B. R., Titus, B. G., & Lands, W. E. M. (1979) · Prostaglandins and Medicine · doi:10.1016/0161-4630(79)90068-5 · Cited by 315
Serhan, C. N., Gotlinger, K., Hong, S., & Arita, M. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.03.005 · Cited by 310
Todoric, J., Löffler, M., Huber, J., Bilban, M., Reimers, M., Kadl, A., Zeyda, M., Waldhäusl, W., & Stulnig, T. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0300-x · Cited by 310
Gronert, K., Maheshwari, N., Khan, N., Hassan, I. R., Dunn, M., & Laniado Schwartzman, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410638200 · Cited by 310
Self-citationQureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
Electrospray ionization and tandem mass spectrometry of eicosanoids
Murphy, R. C., Barkley, R. M., Zemski Berry, K., Hankin, J., Harrison, K., Johnson, C., Krank, J., McAnoy, A., Uhlson, C., & Zarini, S. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.042 · Cited by 231
González‐Périz, A., Planagumà, A., Gronert, K., Miquel, R., López‐Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6250fje · Cited by 225
Self-citationPPAR gamma and human metabolic disease
Chatterjee, K. (2006) · 8th European Congress of Endocrinology incorporating the British Endocrine Societies · Cited by 209
Campbell, E. L., Louis, N. A., Tomassetti, S. E., Canny, G. O., Arita, M., Serhan, C. N., & Colgan, S. P. (2007) · The FASEB Journal · doi:10.1096/fj.07-8473com · Cited by 205
Song, X. M., Fiedler, M., Galuska, D., Ryder, J. W., Fernström, M., Chibalin, A. V., Wallberg-Henriksson, H., & Zierath, J. R. (2002) · Diabetologia · doi:10.1007/s125-002-8245-8 · Cited by 184
Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats
Levy, J. R., Clore, J. N., & Stevens, W. D. (2004) · Hepatology · doi:10.1002/hep.20093 · Cited by 167
Masoodi, M., Mir, A. A., Petasis, N. A., Serhan, C. N., & Nicolaou, A. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3331 · Cited by 143
Song, B., Moon, K., Olsson, N., & Salem, N. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.04.023 · Cited by 117
El‐Badry, A. M., Moritz, W., Contaldo, C., Tian, Y., Graf, R., & Clavien, P. (2007) · Hepatology · doi:10.1002/hep.21625 · Cited by 114
Going nuclear in metabolic and cardiovascular disease
Glass, C. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27913 · Cited by 111
Yamamoto, K., Itoh, T., Abe, D., Shimizu, M., Kanda, T., Koyama, T., Nishikawa, M., Tamai, T., Ooizumi, H., & Yamada, S. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.053 · Cited by 91
Alwayn, I. P. J., Andersson, C., Zauscher, B., Gura, K. M., Nosé, V., & Puder, M. (2005) · Transplantation · doi:10.1097/01.tp.0000150023.86487.44 · Cited by 77
Rousseau‐Ralliard, D., Héliès‐Toussaint, C., Moreau, D., Raederstorff, D., & Grynberg, A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00651.2002 · Cited by 70
Kielar, M. L., Jeyarajah, D. R., Zhou, X. J., & Lu, C. Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000045047.44107.0b · Cited by 62
López‐Parra, M., Titos, E., Horrillo, R., Ferré, N., González‐Périz, A., Martínez‐Clemente, M., Planagumà, A., Masferrer, J. L., Arroyo, V., & Clària, J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800101-jlr200 · Cited by 54
Self-citationTranscellular Regulation of Eicosanoid Biosynthesis
Gronert, K., Clish, C. B., Romano, M., & Serhan, C. N. (2003) · Humana Press eBooks · doi:10.1385/1-59259-263-5:119 · Cited by 54
Self-citationMediator Lipidomics: Search Algorithms for Eicosanoids, Resolvins, and Protectins
Serhan, C. N., Lu, Y., Hong, S., & Yang, R. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)32012-0 · Cited by 48
Werner, A., Havinga, R., Bos, T., Bloks, V. W., Kuipers, F., & Verkade, H. J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2004 · Cited by 47
Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
Ginsberg, H. N. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.08.010 · Cited by 43
Dietary n‐3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats
Rousseau‐Ralliard, D., Héliès‐Toussaint, C., Raederstorff, D., Moreau, D., & Grynberg, A. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1012266005428 · Cited by 33
Cited by
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
“Recent studies have also indicated that metabolic products derived from u-3 FAs, such as 17S-hydroxy-DHA, resolvins, and protectins may play a role in the long term resolution of inflammation and this might attenuate insulin resistance in the context of obesity (González-Périz et al., 2009).”
Omega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 663
Serhan, C. N. (2017) · The FASEB Journal · doi:10.1096/fj.201601222r · Cited by 555
Metadata
- Authors
- González-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López-Parra, M., Arroyo, V., & Clária, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-02-11
- Volume
- 23
- Issue
- 6
- Pages
- 1946-1957
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2163837156
- Cited by
- 555
- References
- 58
- FWCI
- 36.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.